Pharma & Healthcare · Switzerland
Novartis layoffs
We've tracked 4 rounds of Novartis layoffs between Jun 2022 and Sep 2026, affecting 9,360 people in total. None of these cuts were publicly blamed on AI. Headcounts are what was reported at the time, and some may have changed since.
People affected
9K
Across tracked announcements
Announcements
4
Jun 2022 → Sep 2026
AI-attributed
0%
Of affected people
Every tracked announcement
- −130
Novartis said it is cutting up to 130 jobs at a Basel plant by the end of 2027 as other biologics sites take over its work.
About the figure: Up to 130.
Source: SWI swissinfo.ch
- −550
Novartis planned to cut 550 jobs in Switzerland by 2027 as it stops making certain drug products and sterile packaging.
Source: Pharmaceutical Executive
- −680
Novartis said it would cut up to 680 jobs in its drug development organisation over two to three years.
About the figure: Up to 680: around 440 in Switzerland and up to 240 in the United States.
Source: The Globe and Mail (Reuters)
- −8,000
Novartis confirmed plans to cut around 8,000 of its 108,000 jobs worldwide in a restructuring meant to save 1 billion dollars.
Source: Fierce Pharma
Working at Novartis, or somewhere like it?
Check your company against the 15 warning signs we saw before cuts like these, or see how exposed your own role is.
Part of the WorkforceSignal company directory, every event curated from public reporting with conservative AI attribution. See methodology.